Table 3.
Frequency of M. kansasii Isolates and Subtypes by Characteristic, Symptoms at Presentation and Previous Medical History
| Characteristics | M. kansasii N = 33 (%) | M. kansasii Subtypes |
|---|---|---|
| Year | ||
| 2016 | (n = 7) 21% | (I= 5) 9%,(II = 2) 6% |
| 2017 | (n = 10) 30% | (I= 7) 21%,(II = 3) 9% |
| 2018 | (n = 16) 48% | (I= 12) 36%,(II = 3) 9%, (IV = 1) 3% |
| Age | ||
| 0–19 | – | – |
| 20–39 | (n = 5) 15% | (I= 3) 9%,(II = 2) 6% |
| 40–59 | (n = 11) 33% | (I= 9)27%,(II = 3) 9% |
| ≥60 | (n = 17) 51% | (I= 12)66%, (II = 3) 9%, (IV = 1) 3% |
| Gender | ||
| Female | (n = 8) 24% | (I= 7)21%, (II = 1)3% |
| Male | (n = 25) 76% | (IV = 1) 3%,(I= 19) 57%,(II = 5) 18% |
| Symptoms at presentation | ||
| Fever, cough | (n = 9) 27% | (I= 5) 15 %,(II = 4) 12% |
| Fever | (n = 12) 36% | (I= 9) 27 %,(II = 3) 9% |
| Productive cough | (n = 4) 12% | (I= 3) 9 %,(II = 1) 3% |
| Local pain, small pale nodule | (n = 3) 9% | (I= 3) 9% |
| Fever, inflammation and tenderness in joint | (n = 1) 3% | (I= 1) 3% |
| Local abscess and discharge | (n = 1) 3% | (I= 1) 3% |
| Productive cough, thoracic pain & weight loss | (n =1) 3% | (IV= 1)3% |
| Productive cough, fever, weight loss | (n = 2) 6% | (I= 1) 3% |
| Underlying condition | ||
| Treated tuberculosis | (n = 4) 12% | (I= 2) 6%, (II= 2) 6% |
| HIV infection | (n = 5) 15% | (I= 4) 12 %, (IV= 1)3 % |
| Open heart surgery | (n = 3) 9% | (I= 3) 9% |
| COPD | (n = 1) 3% | (I= 1) 3% |
| HCV | (n = 1) 3% | (I= 1) 3% |
| Immunocompromised | (n = 1) 3% | (II=1) 3% |
| Renal failure | (n = 1) 3% | (I= 1) 3% |
| Diabetic | (n = 1) 3% | (I= 1) 3% |
| Pemphigus Vulgaris | (n = 1) 3% | (I= 1) 3% |
| Respiratory failure | (n = 1) 3% | (I= 1) 3% |
| Smoking | (n = 1) 3% | (I= 2) 6% |
| Sarcoma | (n = 1) 3% | (II= 1) 3% |
| Alcoholic | (n = 1) 3% | (I= 1) 3 % |